PG
BSV icon

Prostatis Group’s Vanguard Short-Term Bond ETF BSV Stock Holding History

Prostatis Group’s Portfolio BSV Stock Details BSV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
35,232
-1,818
-5% -$142K 0.64% 39
2026
Q1 		$2.91M Sell
37,050
-5,188
-12% -$408K 0.74% 42
2025
Q4 		$3.33M Buy
42,238
+153
+0.4% +$12.1K 0.79% 38
2025
Q3 		$3.32M Sell
42,085
-81
-0.2% -$6.37K 0.83% 38
2025
Q2 		$3.32M Sell
42,166
-6,582
-14% -$515K 0.95% 27
2025
Q1 		$3.82M Buy
48,748
+5,315
+12% +$413K 1.2% 17
2024
Q4 		$3.36M Sell
43,433
-838
-2% -$65K 0.98% 27
2024
Q3 		$3.48M Sell
44,271
-6,504
-13% -$507K 1.14% 23
2024
Q2 		$3.89M Sell
50,775
-1,000
-2% -$76.3K 1.37% 17
2024
Q1 		$3.97M Buy
51,775
+3,272
+7% +$251K 1.51% 16
2023
Q4 		$3.74M Sell
48,503
-1,745
-3% -$132K 1.56% 16
2023
Q3 		$3.78M Sell
50,248
-105,713
-68% -$7.97M 1.85% 12
2023
Q2 		$3.81M Buy
155,961
+108,508
+229% +$8.27M 1.77% 14
2023
Q1 		$3.64M Sell
47,453
-203
-0.4% -$15.4K 1.92% 14
2022
Q4 		$3.59M Sell
47,656
-2,076
-4% -$156K 2.19% 13
2022
Q3 		$3.72M Sell
49,732
-1,839
-4% -$141K 4.29% 6
2022
Q2 		$3.96M Buy
51,571
+2,681
+5% +$207K 6.17% 4
2022
Q1 		$3.81M Buy
48,890
+44,880
+1,119% +$3.56M 3.05% 8
2021
Q4 		$324K Sell
4,010
-332
-8% -$27K 0.2% 69
2021
Q3 		$356K Sell
4,342
-312
-7% -$25.6K 0.21% 70
2021
Q2 		$382K Sell
4,654
-68,199
-94% -$5.61M 0.26% 67
2021
Q1 		$5.99M Sell
72,853
-24,726
-25% -$2.04M 4.7% 5
2020
Q4 		$8.09M Buy
+97,579
New +$8.08M 6.77% 3

Other funds holding BSV

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prostatis Group's BSV Position: Q2 2026 in Review

Prostatis Group reduced its Vanguard Short-Term Bond ETF (BSV) stake by 4.9% in Q2 2026, selling an estimated $142K and leaving 35,232 shares worth $2.74M. The position accounts for 0.64% of the portfolio, ranked #39.

Prostatis Group first reported a position in BSV in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.09M in Q4 2020. 1,355 funds tracked by Wall St. Rank hold BSV as of Q2 2026.

  • Prostatis Group held 35,232 shares of Vanguard Short-Term Bond ETF worth $2.74M as of Q2 2026.
  • Prostatis Group sold 1,818 Vanguard Short-Term Bond ETF shares in Q2 2026, an estimated $142K.
  • Vanguard Short-Term Bond ETF made up 0.64% of Prostatis Group's portfolio in Q2 2026, its #39 holding.
  • Prostatis Group first reported a position in Vanguard Short-Term Bond ETF in Q4 2020 and has held it in 23 quarters since.
  • Prostatis Group's Vanguard Short-Term Bond ETF position peaked at $8.09M in Q4 2020.
  • 1,355 funds tracked by Wall St. Rank held Vanguard Short-Term Bond ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.